glp-1 drugs for pcos Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives Liraglutide and polycystic ovary syndrome:

Literature Search and Inclusion Criteria This narrative review was based on a targeted search of PubMed, Scopus, and Web of Science, as well as official regulatory agencies, manufacturers of GLP-1RAs, and specialized entities providing economic estimates, to identify relevant publications on GLP-1RAs and obesity

NGs were excised from the mice anesthetized with -chloralose and urethane (0.1 and 1 g kg 1 , i.p.)

doi: 10.1016/j.metabol.2019.154045

The observed association might also reflect ascertainment bias related to known side effects of GLP-1RAs, as common symptoms like nausea and dizziness may prompt investigations that uncover pre-existing vestibular conditions [44]